戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 by (18)F-FDG accumulated in tumors to induce photoimmunotherapy.
2  without compromising therapeutic effects of photoimmunotherapy.
3 ial histologic analyses were conducted after photoimmunotherapy.
4 as reduced by more than 99% within 1 h after photoimmunotherapy.
5 immunoconjugate uptake as a way of enhancing photoimmunotherapy.
6 ion, and laser endoscopy (ML7710) to improve photoimmunotherapy.
7 ing and photosensitizer immunoconjugates for photoimmunotherapy.
8 regs using anti-CD25-F(ab')(2) near-infrared photoimmunotherapy.
9 d with intact IgG for their effectiveness as photoimmunotherapy agents.
10 one of tumors changed size within 24 h after photoimmunotherapy, although diffuse necrosis was observ
11 treated tumors decreased 76% at 75 min after photoimmunotherapy and did not change for 24 h.
12 ultiepitope targeting enhances HER2-targeted photoimmunotherapy and maintains a high degree of specif
13                       Tremendous progress in photoimmunotherapy and nanotechnology has been made to t
14 eight of the tumors in the mice treated with photoimmunotherapy, and the median survival increased fr
15 or monitoring the acute cytotoxic effects of photoimmunotherapy before the tumor begins to shrink, we
16 cal assessment of the therapeutic effects of photoimmunotherapy earlier than anatomic methods that re
17                                     To date, photoimmunotherapy has been demonstrated only with full
18 ese concepts of "tumor-targeted, activatable photoimmunotherapy" in a mouse model of peritoneal carci
19                                              Photoimmunotherapy induces rapid and highly specific nec
20                                              Photoimmunotherapy is a highly cell-selective cancer the
21                                              Photoimmunotherapy may allow targeted photodynamic destr
22                                Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment t
23                                Near-infrared photoimmunotherapy (NIR-PIT) is a novel cancer treatment
24            Previously, we used near-infrared photoimmunotherapy (NIR-PIT), a next-generation cancer c
25                                Near infrared photoimmunotherapy (NIR-PIT), a targeted cancer therapy
26 uggest cationic PICs may have advantages for photoimmunotherapy of disseminated intracavity cancer fo
27                                              Photoimmunotherapy (PIT) involves monoclonal antibodies
28                                              Photoimmunotherapy (PIT) is an emerging low side effect
29 rating D-A interactions into nanosystems for photoimmunotherapy (PIT) is still a novel approach.
30 ugate for combined fluorescent detection and photoimmunotherapy (PIT) of CD44 expressing cells in TNB
31 w type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific ph
32                PIAS works in the same way as photoimmunotherapy (PIT), which has been used to treat r
33          Antibody-based photodynamic therapy-photoimmunotherapy (PIT)-is an ideal modality to improve
34 y (mAb)-based, highly specific phototherapy (photoimmunotherapy; PIT) that uses a near infrared (NIR)
35                                       Cancer photoimmunotherapy represents an intelligent and highly
36 nctional therapeutic modalities for combined photoimmunotherapy requires advanced drug delivery syste
37    Consequently, it seems that multitargeted photoimmunotherapy should also be useful against cancers
38                                              Photoimmunotherapy shows efficacy in destroying liver tu
39 y, although diffuse necrosis was observed in photoimmunotherapy-treated tumors.
40                                              Photoimmunotherapy (using a monoclonal antibody-targeted
41   The uptake of (18)F-FDG in the tumor after photoimmunotherapy was evaluated in cellular uptake stud
42                 Then therapeutic efficacy of photoimmunotherapy was examined by exposing mice to NIR
43                                              Photoimmunotherapy was performed by binding panitumumab
44       Immediate cytotoxic effects induced by photoimmunotherapy were clearly detected by decreased gl
45 ecently developed a cancer-specific therapy, photoimmunotherapy, which uses an antibody-IR700 (photot
46                              A comparison of photoimmunotherapy with 10 J of light delivered at 30 or
47                        Multiepitope targeted photoimmunotherapy with a HER50 and HER66 photosensitize
48  more effective than single-epitope targeted photoimmunotherapy with a single anti-HER2 photosensitiz
49                                              Photoimmunotherapy with the same molar concentration of